Atrium Therapeutics
(NASDAQ) RNA
Atrium Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
N/A
Net Income (TTM)
N/A
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Price
$13.44
Volume
281,726.691
Open
$13.40
Price
$13.44
Volume
281,726.691
Open
$13.40
Previous Close
$13.44
Daily Range
$13.31 - $13.71
52-Week Range
$11.95 - $16.77
Dividend
$0.00
Beta (Volatility)
-0.16 (Low)
Price
$13.44
Volume
281,726.691
Open
$13.40
Previous Close
$13.44
Daily Range
$13.31 - $13.71
52-Week Range
$11.95 - $16.77
RNA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Atrium Therapeutics
RNA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-4%
Return on Equity
0%
Return on Capital
-32%
Return on Assets
-28%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$0.00
Shares Outstanding
0
Volume
281.73K
Short Interest
0.00%
Avg. Volume
1.24M
Financials (TTM)
Gross Profit
$18.62M
Operating Income
$76.81M
EBITDA
$76.49M
Operating Cash Flow
$41.13M
Capital Expenditure
$1.45M
Free Cash Flow
$42.57M
Cash & ST Invst.
$270.00M
Total Debt
$3.67M
Atrium Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$859.00K
N/A
Gross Profit
$859.00K
N/A
Gross Margin
100.00%
N/A
Market Cap
$0.00
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$48.07M
N/A
EBITDA
$47.91M
N/A
Quarterly Fundamentals
Net Cash
$266.33M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$3.67M
N/A
Return on Assets
-27.55%
N/A
Return on Invested Capital
-32.47%
N/A
Free Cash Flow
$20.13M
N/A
Operating Cash Flow
$19.25M
N/A